{"schema_version":"secwatch.filing_event.v1","accession":"0001654954-26-007306","form_type":"8-K","ticker":"ZOMDF","cik":"0001684144","company_name":"Zomedica Corp.","filed_at":"2026-08-05T20:30:26+00:00","discovered_at":"2026-08-05T20:31:11.589074+00:00","generated_at":"2026-08-05T20:31:17.045576+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Zomedica Q2 revenue $9.5M (+37% YoY), net loss down 49% to $3.8M","bullets":["Record Q2 revenue of $9.5M, up 37% YoY; net loss reduced 49% to $3.8M from $7.4M.","Diagnostics segment revenue grew 77% to $1.4M; Therapeutic Devices up 9% to $6.8M.","Cash burn improved 38% to $3.4M; operating expenses down 20% to $10.1M.","Cash and securities $44.1M; 22nd consecutive quarter of YoY revenue growth.","Development Services segment contributed $1.4M in Q2, $3.4M YTD."],"urls":{"canonical":"https://secwatch.observer/filing/0001654954-26-007306","json":"https://secwatch.observer/filing/0001654954-26-007306.json","markdown":"https://secwatch.observer/filing/0001654954-26-007306.md","text":"https://secwatch.observer/filing/0001654954-26-007306.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1684144/000165495426007306/0001654954-26-007306-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1684144/000165495426007306/zom_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-05T20:31:17.045576+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}